Neurotherapeutics Course
  • Home
  • Important Information
  • Course Evaluation
  • Faculty
  • Submit an Application
  • Schedule of Activities
  • Student Instructions
  • Course Materials
  • Resources
  • Course Lecture Videos

Mentor Assignments and Round Robin Schedule will be posted when the course begins.

Mentor Assignments
Round Robin Schedule
Monday, February 8, 2021 

11:00 am – 11:30 am
Overview: The Neurotherapeutics Discovery and Development Process
Michael A. Rogawski, MD, PhD, University of California, Davis

11:30 am – 12:15 pm
Session 1: Target and Pathway Interrogation
James Inglese, PhD, National Center for Advancing Translational Sciences, NIH

12:15 pm – 12:45 pm
Break

12:45 pm  – 1:30 pm
Session 2: Biology Basics for Identifying Hits
William Janzen, BS, Ribometrix, Inc.

1:30 pm – 2:15 pm
Session 3: Moving from Hit to Lead to Clinical Candidate
James Barrow, PhD, Johns Hopkins School of Medicine

2:15 noon – 2:30 pm
Break

2:30 pm – 3:15 pm
Session 4: Antibody-Based Therapies
Gai Ayalon, PhD, Ultragenyx

3:15 pm – 4:00 pm
Meet with Mentors

4:15 pm – 5:00 pm
Office Hourse with Course Directors and Faculty 
Please drop by if you have questions for them.

Tuesday, February 9, 2021

11:00 am – 11:05 am
Welcome & Overview of the Day

11:05 am – 11:50 pm
Session 5: Intellectual Property
Jeffrey W. Childers, JD, PhD, Casimir Jones S.C.

11:50 am – 12:35 pm 
Invited Guest Speaker: The Story of Risdiplam/Everysdi 
Alexander Stephan, PhD, Roche Pharma Research and Early Development

12:35 pm – 1:05 pm
Break

1:05 pm – 1:50 am
Session 6: ADME
Kennan Marsh, PhD, AbbVie

1:50 pm – 2:35 pm
Session 7: Preclinical Models of CNS Disease: Efficacy and Target Engagement
Christian Mirescu, PhD, Merck

2:35 pm – 2:50 pm
Break

2:50 pm – 4:15 pm 
Engagement Exercise: Round Robin Day 1

4:30 pm – 5:15 pm 
Office Hours with Course Directors and Faculty
Please drop by if you have questions for them.

Wednesday, February 10, 2021

11:00 am – 11:05 am
Welcome & Overview of the Day

11:05 am – 11:35 am
Session 8a: Formulation and Routes of Administration
Maureen Donovan, PhD, University of Iowa

11:35 am – 11:50 am
Session 8b: Alternative Routes of Administration
James Cloyd III, PharmD, University of Minnesota

11:50 am – 12:35 pm
Session 9: Gene Therapy
Edgardo Rodríguez-Lebrón, PhD, McKnight Brain Institute, University of Florida

12:35 am – 1:05 pm
Break

1:05 pm – 1:50 pm
Session 10: Toxicology
Adaline Smith, PhD, DABT

1:50 am – 2:35 pm
Session 11: IND Enabling Studies and Preparation of the IND
Edward Spack, PhD, Medared 

2:35 pm – 2:50 pm
Break

2:50 pm – 4:15 pm
Engagement Exercise 2: Round Robin Day 2

4:30 pm – 5:15 pm 
Office Hours with Course Directors and Faculty
Please drop by if you have questions for them.

Thursday, February 11, 2021

11:00 am – 11:05 am
Welcome & Overview of the Day

​11:50 am – 12:35 pm
Session 13: Clinical Considerations in the Non-Clinical Phase of Drug Discovery and Development
James J. Vornov, MD, PhD, Johns Hopkins School of Medicine and Medpace

12:35 pm – 1:05 pm
Break

1:05 pm – 1:50 pm 
Session 14: Funding Academic Drug Discovery Research
Charles L. Cywin, PhD, NIH/NINDS

Engagement Exercise: Round Robin 3

3:10 pm – 3:55 pm 
Office Hours with Course Directors and Faculty
Please drop by if you have questions for them.

Friday, February 12, 2021

11:00 am – 11:15 am
Welcome & Overview of the Day

11:15 am – 1:45 pm
Engagement Exercise: Student Presentations

1:45 pm – 2:00 pm 
Conclusion: Where do we go from here? Course evaluation and survey
Course Directors

2:00 pm
Adjourn
Picture
Picture